Management of Skin and Soft Tissue Infections in a County Correctional Center: A Quality Improvement Project.
The number of antibiotic-resistant infections continues to increase. In 2005, there were nearly 11,406 deaths from methicillin-resistant Staphylococcus aureus (MRSA) infection in the United States. Since 1980, the United States has seen a 300% increase in the rate of incarceration. This is noteworthy because individuals who enter correctional facilities have an increased risk for MRSA skin and soft tissue infections (SSTIs) and the risk of colonization proportional to the length of stay. Correctional institutions have a vested interest in improving the screening and treatment of MRSA SSTIs, as it is a costly and potentially preventable problem. This article describes the process of implementing an MRSA screening and treatment policy in a county correctional center.
Creighton University, Omaha, NE, USA lisamullen1988@gmail.com.
Lisa A
LA
Mullen
Creighton University, Omaha, NE, USA.
Catherine
C
O'Keefe
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008403:Mass Screening; D055118:Medication Adherence; D055624:Methicillin-Resistant Staphylococcus aureus; D008875:Middle Aged; D020380:Needs Assessment; D011330:Prisons / Q000458:organization & administration*; D058996:Quality Improvement / Q000458:organization & administration*; D012307:Risk Factors; D018461:Soft Tissue Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D013207:Staphylococcal Skin Infections / Q000175:diagnosis / Q000188:drug therapy; D014481:United States; D055815:Young Adult
D000900:Anti-Bacterial Agents
MRSA; best practices; correctional facilities; policy; skin and soft tissue infections